Annual SGA
$61.15 M
+$4.31 M+7.58%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual SGA is $61.15 million, with the most recent change of +$4.31 million (+7.58%) on December 31, 2023.
- During the last 3 years, MRNS annual SGA has risen by +$42.60 million (+229.68%).
- MRNS annual SGA is now at all-time high.
Performance
MRNS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$12.57 M
-$4.14 M-24.76%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly SGA is $12.57 million, with the most recent change of -$4.14 million (-24.76%) on September 30, 2024.
- Over the past year, MRNS quarterly SGA has stayed the same.
- MRNS quarterly SGA is now -32.50% below its all-time high of $18.63 million, reached on March 31, 2024.
Performance
MRNS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.50 B
-$140.49 M-5.96%
September 30, 2024
Summary
- As of February 8, 2025, MRNS TTM SGA is -$2.50 billion, with the most recent change of -$140.49 million (-5.96%) on September 30, 2024.
- Over the past year, MRNS TTM SGA has dropped by -$2.56 billion (-4050.86%).
- MRNS TTM SGA is now -3964.18% below its all-time high of -$61.50 million.
Performance
MRNS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MRNS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.6% | 0.0% | -4050.9% |
| 3 y3 years | +229.7% | -14.2% | -4497.2% |
| 5 y5 years | +596.1% | -14.2% | -4497.2% |
MRNS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.0% | -32.5% | +18.4% | -67.2% | at low |
| 5 y | 5-year | at high | +433.8% | -32.5% | +324.8% | -192.0% | at low |
| alltime | all time | at high | +8826.0% | -32.5% | +6881.1% | -3964.2% | at low |
Marinus Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $12.57 M(-24.8%) | $63.27 M(-3.5%) |
| Jun 2024 | - | $16.71 M(-10.3%) | $65.56 M(+1.5%) |
| Mar 2024 | - | $18.63 M(+21.3%) | $64.57 M(+5.6%) |
| Dec 2023 | $61.15 M(+7.6%) | $15.36 M(+3.3%) | $61.15 M(+1.2%) |
| Sep 2023 | - | $14.87 M(-5.4%) | $60.45 M(+2.5%) |
| Jun 2023 | - | $15.72 M(+3.4%) | $58.97 M(-2.2%) |
| Mar 2023 | - | $15.20 M(+3.7%) | $60.31 M(+6.1%) |
| Dec 2022 | $56.84 M(+52.5%) | $14.66 M(+9.5%) | $56.84 M(+7.6%) |
| Sep 2022 | - | $13.39 M(-21.5%) | $52.81 M(+8.1%) |
| Jun 2022 | - | $17.06 M(+45.4%) | $48.87 M(+26.5%) |
| Mar 2022 | - | $11.74 M(+10.5%) | $38.64 M(+3.7%) |
| Dec 2021 | $37.28 M(+101.0%) | $10.62 M(+12.4%) | $37.28 M(+14.1%) |
| Sep 2021 | - | $9.45 M(+38.4%) | $32.66 M(+17.6%) |
| Jun 2021 | - | $6.83 M(-34.2%) | $27.77 M(+10.8%) |
| Mar 2021 | - | $10.38 M(+72.8%) | $25.08 M(+35.2%) |
| Dec 2020 | $18.55 M(+61.9%) | $6.01 M(+31.6%) | $18.55 M(+19.6%) |
| Sep 2020 | - | $4.56 M(+10.5%) | $15.50 M(+16.9%) |
| Jun 2020 | - | $4.13 M(+7.3%) | $13.27 M(+14.0%) |
| Mar 2020 | - | $3.85 M(+30.1%) | $11.64 M(+1.6%) |
| Dec 2019 | $11.46 M(+30.4%) | $2.96 M(+27.2%) | $11.46 M(+7.2%) |
| Sep 2019 | - | $2.33 M(-7.0%) | $10.68 M(+2.4%) |
| Jun 2019 | - | $2.50 M(-31.8%) | $10.43 M(+1.6%) |
| Mar 2019 | - | $3.67 M(+67.7%) | $10.26 M(+16.8%) |
| Dec 2018 | $8.79 M | $2.19 M(+5.5%) | $8.78 M(+7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $2.07 M(-11.3%) | $8.19 M(+6.5%) |
| Jun 2018 | - | $2.34 M(+6.9%) | $7.69 M(+9.2%) |
| Mar 2018 | - | $2.19 M(+37.3%) | $7.04 M(+5.6%) |
| Dec 2017 | $6.67 M(+6.9%) | $1.59 M(+1.4%) | $6.67 M(+1.1%) |
| Sep 2017 | - | $1.57 M(-7.1%) | $6.59 M(+0.6%) |
| Jun 2017 | - | $1.69 M(-6.7%) | $6.55 M(+1.6%) |
| Mar 2017 | - | $1.81 M(+19.4%) | $6.45 M(+3.3%) |
| Dec 2016 | $6.24 M(+13.1%) | $1.52 M(-0.7%) | $6.24 M(+1.2%) |
| Sep 2016 | - | $1.53 M(-3.6%) | $6.16 M(+2.5%) |
| Jun 2016 | - | $1.59 M(-1.1%) | $6.01 M(+5.8%) |
| Mar 2016 | - | $1.60 M(+11.2%) | $5.68 M(+2.8%) |
| Dec 2015 | $5.52 M(+70.8%) | $1.44 M(+4.6%) | $5.52 M(+0.7%) |
| Sep 2015 | - | $1.38 M(+9.8%) | $5.48 M(+10.3%) |
| Jun 2015 | - | $1.25 M(-13.3%) | $4.97 M(+19.1%) |
| Mar 2015 | - | $1.45 M(+3.1%) | $4.18 M(+28.7%) |
| Dec 2014 | $3.23 M(+162.8%) | $1.40 M(+61.6%) | $3.25 M(+47.4%) |
| Sep 2014 | - | $868.00 K(+89.5%) | $2.20 M(+33.7%) |
| Jun 2014 | - | $458.00 K(-11.2%) | $1.65 M(+9.6%) |
| Mar 2014 | - | $516.00 K(+43.4%) | $1.50 M(+28.8%) |
| Dec 2013 | $1.23 M(+79.4%) | $359.80 K(+14.8%) | $1.17 M(+44.6%) |
| Sep 2013 | - | $313.40 K(-0.2%) | $807.40 K(+63.4%) |
| Jun 2013 | - | $313.90 K(+74.3%) | $494.00 K(+174.3%) |
| Mar 2013 | - | $180.10 K | $180.10 K |
| Dec 2012 | $685.10 K | - | - |
FAQ
- What is Marinus Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual SGA year-on-year change?
- What is Marinus Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly SGA year-on-year change?
- What is Marinus Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals TTM SGA year-on-year change?
What is Marinus Pharmaceuticals annual SGA?
The current annual SGA of MRNS is $61.15 M
What is the all time high annual SGA for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual SGA is $61.15 M
What is Marinus Pharmaceuticals annual SGA year-on-year change?
Over the past year, MRNS annual SGA has changed by +$4.31 M (+7.58%)
What is Marinus Pharmaceuticals quarterly SGA?
The current quarterly SGA of MRNS is $12.57 M
What is the all time high quarterly SGA for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly SGA is $18.63 M
What is Marinus Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, MRNS quarterly SGA has changed by $0.00 (0.00%)
What is Marinus Pharmaceuticals TTM SGA?
The current TTM SGA of MRNS is -$2.50 B
What is the all time high TTM SGA for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high TTM SGA is -$61.50 M
What is Marinus Pharmaceuticals TTM SGA year-on-year change?
Over the past year, MRNS TTM SGA has changed by -$2.56 B (-4050.86%)